| Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial A Hildesheim, R Herrero, S Wacholder, AC Rodriguez, D Solomon, ... Jama 298 (7), 743-753, 2007 | 820 | 2007 |
| Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica R Herrero, W Quint, A Hildesheim, P Gonzalez, L Struijk, HA Katki, ... PloS one 8 (7), e68329, 2013 | 568 | 2013 |
| Oral human papillomavirus in healthy individuals: a systematic review of the literature AR Kreimer, RK Bhatia, AL Messeguer, P González, R Herrero, ... Sexually transmitted diseases 37 (6), 386-391, 2010 | 414 | 2010 |
| Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine AR Kreimer, AC Rodriguez, A Hildesheim, R Herrero, C Porras, ... Journal of the National Cancer Institute 103 (19), 1444-1451, 2011 | 397 | 2011 |
| Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease AK Chaturvedi, HA Katki, A Hildesheim, AC Rodríguez, W Quint, ... The Journal of infectious diseases 203 (7), 910-920, 2011 | 354 | 2011 |
| European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk J Schüz, C Espina, P Villain, R Herrero, ME Leon, S Minozzi, I Romieu, ... Cancer epidemiology 39, S1-S10, 2015 | 295 | 2015 |
| Complete genome sequence of the sugarcane nitrogen-fixing endophyte Gluconacetobacter diazotrophicus Pal5 M Bertalan, R Albano, V de Pádua, L Rouws, C Rojas, A Hemerly, ... BMC genomics 10, 1-17, 2009 | 272 | 2009 |
| HPV16 E7 genetic conservation is critical to carcinogenesis L Mirabello, M Yeager, K Yu, GM Clifford, Y Xiao, B Zhu, M Cullen, ... Cell 170 (6), 1164-1174. e6, 2017 | 268 | 2017 |
| Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial AR Kreimer, P González, HA Katki, C Porras, M Schiffman, AC Rodriguez, ... The lancet oncology 12 (9), 862-870, 2011 | 247 | 2011 |
| Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial M Safaeian, C Porras, Y Pan, A Kreimer, JT Schiller, P Gonzalez, ... Cancer Prevention Research 6 (11), 1242-1250, 2013 | 241 | 2013 |
| Present status of human papillomavirus vaccine development and implementation R Herrero, P González, LE Markowitz The Lancet Oncology 16 (5), e206-e216, 2015 | 233 | 2015 |
| Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and-18 infections M Safaeian, C Porras, M Schiffman, AC Rodriguez, S Wacholder, ... Journal of the National Cancer Institute 102 (21), 1653-1662, 2010 | 210 | 2010 |
| Cervicovaginal microbiome and natural history of HPV in a longitudinal study M Usyk, CP Zolnik, PE Castle, C Porras, R Herrero, A Gradissimo, ... PLoS pathogens 16 (3), e1008376, 2020 | 207 | 2020 |
| Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica R Herrero, S Wacholder, AC Rodríguez, D Solomon, P González, ... Cancer discovery 1 (5), 408-419, 2011 | 197* | 2011 |
| Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis S Pereyre, P Gonzalez, B De Barbeyrac, A Darnige, H Renaudin, ... Antimicrobial agents and chemotherapy 46 (10), 3142-3150, 2002 | 193 | 2002 |
| Common genetic variants and risk for HPV persistence and progression to cervical cancer SS Wang, P Gonzalez, K Yu, C Porras, Q Li, M Safaeian, AC Rodriguez, ... PloS one 5 (1), e8667, 2010 | 183 | 2010 |
| Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica R Herrero, A Hildesheim, AC Rodríguez, S Wacholder, C Bratti, ... Vaccine 26 (37), 4795-4808, 2008 | 180 | 2008 |
| Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment A Hildesheim, P Gonzalez, AR Kreimer, S Wacholder, J Schussler, ... American journal of obstetrics and gynecology 215 (2), 212. e1-212. e15, 2016 | 157 | 2016 |
| Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer SS Wang, MC Bratti, AC Rodríguez, R Herrero, RD Burk, C Porras, ... The Journal of infectious diseases 199 (1), 20-30, 2009 | 154 | 2009 |
| Evaluation of durability of a single dose of the bivalent HPV vaccine: the CVT trial AR Kreimer, JN Sampson, C Porras, JT Schiller, T Kemp, R Herrero, ... JNCI: Journal of the National Cancer Institute 112 (10), 1038-1046, 2020 | 146 | 2020 |
